Atlas Trials

QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration

Clinical trial NCT06766565 · COMPLETED

Trial details

NCT number
NCT06766565
Sponsor
Fuzhou General Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
NSCLC
Start date
2021-12-08
Primary completion
2022-12-08
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.